Trial | NCT00097422  Report issue

Title

OPT-80 in Clostridium Difficile-Associated Diarrhea (CDAD)
An Open-Label, Dose Ranging, Randomized Clinical Evaluation of OPT-80 in Patients With Clostridium Difficile-Associated Diarrhea (CDAD)

  • Phase

    Phase 2

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    None
The purpose of this study is to investigate the safety and perform preliminary clinical evaluation in patients with mild to moderate CDAD.
This is a dose-finding study to select a safe and efficacious dose of OPT-80. Patients will be evaluated for safety and efficacy and pharmacokinetic parameters will be investigated.
Study Started
Nov 01
2004
Primary Completion
Apr 01
2005
Study Completion
Apr 01
2005
Last Update
Mar 27
2017

Drug OPT-80

Criteria 

Inclusion Criteria:

Patients with CDAD

Exclusion Criteria:

Patients with severe CDAD
No Results Posted